CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial Contemporary use of drug-coated balloons in coronary artery disease: Where are we now? The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability A prospective natural-history study of coronary atherosclerosis Impact of Artificial Intelligence on Interventional Cardiology: From Decision-Making Aid to Advanced Interventional Procedure Assistance The Year in Cardiovascular Medicine 2020: Coronary Intervention Treating Multivessel Coronary Artery Disease in ST-Segment Elevation Myocardial Infarction: Why, How, and When? Comparison of Heart Team vs Interventional Cardiologist Recommendations for the Treatment of Patients With Multivessel Coronary Artery Disease Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia Rotational atherectomy and new-generation drug-eluting stent implantation

Guideline2018,46(12):933-964.

JOURNAL:中华心血管病杂志 Article Link

中国肺高血压诊断和治疗指南2018

中华医学会心血管病学分会肺血管病学组, 中华心血管病杂志编辑委员会。 Keywords: pulmonary arterial hypertension; guideline

ABSTRACT


2007年7月中华医学会心血管病学分会、中华心血管病杂志编辑委员会联合发布了我国"肺动脉高压筛查诊断与治疗专家共识",该共识参考2003年在意大利威尼斯举办的第3次世界肺高血压大会对肺高血压的定义、临床分类、诊断流程和治疗策略,基于当时国际上临床实践的现状,并结合我国实际情况,对我国肺动脉高压(pulmonary arterial hypertension,PAH)的筛查、诊断与治疗均提出了切实可行的建议,对规范临床医生的诊疗行为、提高我国肺高血压临床诊治水平发挥了重要作用。